Page last updated: 2024-09-05

sb 216763 and Liver Neoplasms

sb 216763 has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SH; Kim, YC; Kwon, HY; Lee, JH; Sohn, EJ; Son, HS; Woo, HJ; Yun, M1

Other Studies

1 other study(ies) available for sb 216763 and Liver Neoplasms

ArticleYear
Activation of AMP-activated protein kinase and phosphorylation of glycogen synthase kinase3 β mediate ursolic acid induced apoptosis in HepG2 liver cancer cells.
    Phytotherapy research : PTR, 2013, Volume: 27, Issue:11

    Topics: AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Adhesion Molecules; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Indoles; Leupeptins; Liver Neoplasms; Maleimides; Membrane Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; TOR Serine-Threonine Kinases; Triterpenes; Ubiquitination; Ursolic Acid

2013